Skip to main content
. 2021 Jul 23;5(1):e1–e11. doi: 10.1093/jcag/gwab023

Table 1.

Study characteristics

Type of study Study Sample size Patient age (mean) CDI severity F/U duration (weeks) FMT administration Amount of fecal material delivered per FMT Average # of FMT needed to treat FMT regimen PMC driven (12) Antibiotic usage* # of patients achieving overall cure from FMT Time to discharge after final FMT therapy (Weeks) NIH Score for Case series or RCTs
Case Series Weingarden (11) 4 72.75 SFCDI 27 Lower endoscopy N/A 1.6 No Physician’s discretion 2/4 3.5 7
Gundacker (26) 8 68 SFCDI 65.7 Upper GI + lower endoscopy + enema 30g 1.5 No Physician’s discretion 6/8 unclear 8
Alukal (27) 9 67.78 F 16 Upper GI + lower endoscopy + enema 50g 1 No Physician’s discretion 8/9 20.78 8
Kelly (10) 11 67 SFCDI 12 Upper GI + lower endoscopy N/A 1.45 No Physician’s discretion 10/11 unclear 8
Zainah (28) 14 73.4 S 14.3 Upper GI + lower endoscopy 30-50g 1.43 No Physician’s discretion 11/14 unclear 6
Aroniadis (29) 17 66 SFCDI 45.6 Upper GI + lower endoscopy + enema N/A unclear No Physician’s discretion 15/17 unclear 5
Ianiro (30) 48 74.87 SFCDI 63.7 Lower endoscopy ≥50g 2.08 No Physician’s discretion 45/48 6.18 9
Fischer (19) 57 72 SFCDI 12 Lower endoscopy 50-200g 1.6 Yes Part of protocol 52/57 11 9
Case control Tixier (25) 16 62.9 SFCDI 30 Lower endoscopy N/A 1.4 Yes Part of protocol 13/16 unclear 8
Randomized Trial Ianiro (14) 56 74.5 SFCDI 8 Lower endoscopy ≥50g 2.25 Yes Part of protocol 49/56 unclear 10

*More details are given in Supplementary Table 5.